| Literature DB >> 28574616 |
Afsane Bahrami1,2,3, Seyed Mahdi Hassanian2,4, Majid Khazaei5, Malihe Hasanzadeh6, Soodabeh Shahidsales7, Mina Maftouh2, Gordon A Ferns8, Amir Avan2,7.
Abstract
The tumor microenvironment (TME) is cellular environment in addition to harboring carcinoma cells, consists of different components (e.g., blood vessels, immune cells, fibroblasts, bone marrow-derived inflammatory cells, lymphocytes, signaling molecules, and the extracellular matrix) that have an essential role on drug activity and efficacy. There is growing body of evidence showing its involvement in the progression and metastasis of different cancers, including breast cancer (BC). These observations provide a proof of concept of targeting TME compartments as a novel potential therapeutic approach in treatment of this malignancy, which is the main interested for current review. J. Cell. Biochem. 119: 111-122, 2018.Entities:
Keywords: BREAST CANCER; FIBROBLAST; MACROPHAGE; SRTOMA; TUMOR MICROENVIRONMENT
Mesh:
Substances:
Year: 2017 PMID: 28574616 DOI: 10.1002/jcb.26183
Source DB: PubMed Journal: J Cell Biochem ISSN: 0730-2312 Impact factor: 4.429